Fingerprint
Dive into the research topics of 'Adding cetuximab to a standard chemotherapy regimen containing bevacizumab in first-line therapy for colorectal cancer decreases efficacy: Results from the CAIRO2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically